Over the Counter Medications with Generic Names Beginning ‘R’

Page 1 of 32 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Epi-Mist (RACEPINEPHRINE HYDROCHLORIDE)

INDICATION USAGE JPEG WARNING SECTION DOSAGE AND ADMINISTRATION DIRECTIONS: Do not take more than directed. Place your lips around the mouthpiece and squeeze the bulb while inhaling…

DRNATURALHEALING INC20 March 2018

S2 (Racepinephrine Hydrochloride)

For temporary relief of mild symptoms of intermittent asthma: Wheezing. Tightness of chest. Shortness of breath. Warnings: Asthma alert Because asthma may be life threatening, see a…

Nephron SC, Inc.11 January 2021

S2 Racepinephrine MULTI-DOSE (Racepinephrine Hydrochloride)

For temporary relief of mild symptoms of intermittent asthma: Wheezing. Tightness of chest. Shortness of breath. Warnings: Asthma alert Because asthma may be life threatening, see a…

Nephron SC, Inc.11 January 2021

Asthmanefrin (Racepinephrine Hydrochloride)

For temporary relief of mild symptoms of intermittent asthma: Wheezing. Tightness of chest. Shortness of breath. Warnings: Asthma alert: Because asthma may be life threatening, see a…

Nephron Pharmaceuticals Corporation11 January 2021

Racepinephrine (Racepinephrine Hydrochloride)

For temporary relief of mild symptoms of intermittent asthma: Wheezing. Tightness of chest. Shortness of breath. Warnings: Asthma alert Because asthma may be life threatening, see a…

NuCare Pharmaceuticals,Inc.22 February 2021

Page 1 of 32 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

Hospira Issues A Voluntary Nationwide Recall for One Lot of Sterile Water for Injection, USP, Due to the Potential Presence of Visible Particulate
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot DN9185 of Sterile Water for Injection, USP, 100 mL Single Dose Glass Fliptop Vial, to the hospital/institution level due to a confirmed customer report for a single vial with a visible…
Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection, USP and One Lot of 1% Lidocaine HCl Injection, USP Due to Mislabeling
Mon, 03 May 2021. Hospira, Inc., a Pfizer company, is voluntarily recalling lot EG6023 of 0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and lot EG8933 of 1% Lidocaine HCl Injection, USP 30 mL, to the hospital/institution level due to mislabeling whereby a…

DrugInserts.com

Information Sections

RSS Feeds

About

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.